New York is currently home to 4507 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Ovarian Function Following Intraovarian Injection of PRP
Recruiting
Consenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).
Gender:
FEMALE
Ages:
Between 21 years and 44 years
Trial Updated:
07/09/2024
Locations: Center for Human Reproduction, New York, New York
Conditions: Diminished Ovarian Reserve, Diminished Ovarian Reserve Due to Advanced Maternal Age
Performance of WOUNDCHEK Bacterial Status
Recruiting
The purpose of this clinical study is to evaluate the performance of WOUNDCHEKā„¢ Bacterial Status (WCBS) when the test result is used to inform treatment decisions.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/08/2024
Locations: Northwell Health Comprehensive Wound Healing & Hyperbaric Center, Lake Success, New York
Conditions: Wound Heal
Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health
Recruiting
The investigators long-term goal is to better understand novel interventions to promote cardiovascular health in humans. The goal of the proposed research is to investigate whether there is sex-specificity in the effects of dietary capsaicin on mechanisms regulating nitric oxide (NO) bioavailability, its effect on key markers of cardiovascular (CV) health, including BP, macro- and microvascular function, and arterial stiffness. This knowledge will provide critical insight into the effects of die... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/08/2024
Locations: Skidmore College, Saratoga Springs, New York
Conditions: Pre Hypertension, Hypertension
Intracervical Balloon Placement With Nitrous Oxide Administration
Recruiting
This randomized controlled trial aims to compare the effectiveness of nitrous oxide versus oxygen in facilitating the successful placement of a Foley balloon catheter for cervical ripening and induction of labor.
Gender:
FEMALE
Ages:
Between 18 years and 45 years
Trial Updated:
07/05/2024
Locations: Maimonides Medical Center OB/GYN, Brooklyn, New York
Conditions: Labor Pain, Induced; Birth
67Cu-SARTATEā„¢ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma
Recruiting
The aim of this study is to evaluate the safety and efficacy of 67Cu-SARTATE in pediatric patients with high-risk neuroblastoma.
Gender:
ALL
Ages:
All
Trial Updated:
07/05/2024
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma
Suicide Treatment Alternatives for Teens
Recruiting
Quasi-Randomized trial to compare inpatient care versus outpatient crisis intervention clinic. This study plans to enroll up to 1,000 participants across 4 sites in a 5 years period.
Gender:
ALL
Ages:
Between 12 years and 18 years
Trial Updated:
07/03/2024
Locations: Northwell Health, Glen Oaks, New York
Conditions: Suicidal Ideation
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
Recruiting
The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators want to study the correlation of having a 3D printed model with improvement in patient outcomes and compare those with patients who have had a VAD placement without a 3D model.
Gender:
ALL
Ages:
All
Trial Updated:
07/03/2024
Locations: Montefiore Medical Center, Bronx, New York
Conditions: Congenital Heart Disease
Longitudinal Endpoint Assessment of Disease Burden in HD
Recruiting
LEAD-HD is intended to collect and analyze self-reported health information from individuals with Huntington Disease (HD) or prodromal HD participating in a 24-month longitudinal natural history study using remote technologies.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/02/2024
Locations: Huntington Study Group, Rochester, New York
Conditions: Huntington Disease
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
Recruiting
A randomized, double blind, study of dronabinol as a palliative agent in the treatment of pain, inflammation, and other complications of sickle cell disease (SCD).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/02/2024
Locations: Mount Sinai Hospital, New York, New York
Conditions: Sickle Cell Disease
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC
Recruiting
The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC
Gender:
ALL
Ages:
Between 2 years and 17 years
Trial Updated:
07/02/2024
Locations: Albany Medical College, Albany, New York
Conditions: Neurogenic Detrusor Overactivity
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Recruiting
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune checkpoint therapy with atezolizumab in participant with recurrent and/or persistent endometrial cancer. The main protocol provides a platform for genomic screening with homogeneous basic eligibility criteria in order to direct study participants into biomarker-matched study cohorts consisting of testing targeted agents.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
07/02/2024
Locations: Roswell Park, Buffalo, New York
Conditions: Endometrial Cancer
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Recruiting
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Gender:
ALL
Ages:
All
Trial Updated:
07/02/2024
Locations: Memorial Sloan Kettering Cancer Center - New York, New York, New York
Conditions: Neoplasms